🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/07/2001 | 6,26 | 6,34 | 5,93 | 6,06 | -4,19% | 6,55% | 177.800 |
| 18/07/2001 | 6,25 | 6,40 | 6,13 | 6,32 | +1,20% | 4,40% | 128.600 |
| 17/07/2001 | 6,35 | 6,35 | 6,05 | 6,25 | -1,19% | 4,73% | 215.200 |
| 16/07/2001 | 6,35 | 6,45 | 6,21 | 6,32 | +1,53% | 3,86% | 211.600 |
| 13/07/2001 | 6,28 | 6,40 | 6,00 | 6,23 | -0,08% | 6,37% | 222.400 |
| 12/07/2001 | 6,24 | 6,33 | 6,16 | 6,23 | -0,32% | 2,72% | 134.000 |
| 11/07/2001 | 6,11 | 6,28 | 6,04 | 6,25 | +4,17% | 3,93% | 640.800 |
| 10/07/2001 | 6,18 | 6,18 | 5,98 | 6,00 | -2,68% | 3,32% | 262.800 |
| 09/07/2001 | 6,00 | 6,25 | 5,94 | 6,17 | +0,90% | 5,25% | 109.400 |
| 06/07/2001 | 6,43 | 6,43 | 6,00 | 6,11 | -2,78% | 6,69% | 449.200 |
| 05/07/2001 | 6,40 | 6,40 | 6,25 | 6,29 | -1,41% | 2,34% | 1.196.800 |
| 03/07/2001 | 6,50 | 6,50 | 6,38 | 6,38 | -1,39% | 1,92% | 113.000 |
| 02/07/2001 | 6,61 | 6,61 | 6,38 | 6,47 | -3,15% | 3,48% | 337.000 |
| 29/06/2001 | 6,18 | 6,81 | 6,18 | 6,68 | +7,66% | 10,20% | 549.200 |
| 28/06/2001 | 5,97 | 6,22 | 5,97 | 6,20 | +4,82% | 4,27% | 199.400 |
| 27/06/2001 | 6,13 | 6,23 | 5,76 | 5,92 | -3,74% | 7,67% | 539.200 |
| 26/06/2001 | 6,10 | 6,15 | 5,65 | 6,15 | +1,65% | 8,12% | 143.400 |
| 25/06/2001 | 6,07 | 6,07 | 5,65 | 6,05 | +0,33% | 6,92% | 113.200 |
| 22/06/2001 | 6,15 | 6,15 | 5,98 | 6,03 | -0,58% | 2,85% | 159.600 |
| 21/06/2001 | 6,08 | 6,25 | 6,05 | 6,06 | -1,54% | 3,37% | 374.600 |
| 20/06/2001 | 6,65 | 6,80 | 6,08 | 6,16 | -6,74% | 10,83% | 643.000 |
| 19/06/2001 | 6,63 | 6,68 | 6,60 | 6,60 | -0,38% | 1,13% | 98.600 |
| 18/06/2001 | 6,62 | 6,75 | 6,61 | 6,63 | +0,61% | 2,19% | 111.400 |
| 15/06/2001 | 6,50 | 6,80 | 6,35 | 6,59 | +0,92% | 7,00% | 349.000 |
| 14/06/2001 | 6,70 | 6,75 | 6,20 | 6,53 | -4,47% | 8,21% | 315.000 |
| 13/06/2001 | 6,88 | 6,88 | 6,71 | 6,83 | -0,07% | 2,40% | 26.400 |
| 12/06/2001 | 7,05 | 7,05 | 6,67 | 6,84 | -2,08% | 5,39% | 173.400 |
| 11/06/2001 | 7,13 | 7,16 | 6,98 | 6,98 | -3,72% | 2,53% | 280.400 |
| 08/06/2001 | 7,12 | 7,46 | 7,02 | 7,25 | +2,84% | 6,25% | 379.400 |
| 07/06/2001 | 6,93 | 7,07 | 6,93 | 7,05 | +1,00% | 2,09% | 200.600 |